{
    "clinical_study": {
        "@rank": "126097", 
        "arm_group": [
            {
                "arm_group_label": "Chondrocyte implantation", 
                "arm_group_type": "Experimental", 
                "description": "From a previous biopsy, articular cartilage matrix is digested and chondrocytes are cultured in 2 passages until implants with at least 6,000,000 cells are constructed. These constructus of 8 mm in diameter are implanted arthroscopically by means of biodegradable anchor (MINILOK QUICKANCHOR TM from DePuy-Mitek ) located at the defect and tied securely."
            }, 
            {
                "arm_group_label": "Microfractures", 
                "arm_group_type": "Experimental", 
                "description": "Subchondral bone perforations that allow a clot to be formed, and subsequent scar at the cartilage defect area."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a phase III, randomised controlled trial of matrix-encapsulated chondrocyte\n      implantation procedure compared to the microfracture procedure in the repair of symptomatic\n      cartilage lesions of the knee.  Eligible patients were asked for informed consent\n      preoperatively and randomised for chondrocyte implantation of microfractures.  Those\n      patients allocated to the chondrocyte implantation group will be harvested at time of first\n      arthroscopic procedure and concurrent lesions were treated, as meniscus repair, ligament\n      reconstruction, or malalignment corrected.  The patients allocated to microfracture will be\n      treated at the time of the only arthroscopic procedure. Both groups will have the same\n      rehabilitation program. Prospective clinical, radiographic and magnetic resonance imaging\n      will be performed as main outcomes."
        }, 
        "brief_title": "Arthroscopic Autologous Chondrocyte Implantation Versus Microfractures", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Tear; Knee, Cartilage, Articular", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with symptomatic single chondral lesions of the knee from 1 to 4 cm2.\n\n          -  Signed patient informed consent.\n\n          -  Agree to adhere to rehabilitation protocol.\n\n        Exclusion Criteria:\n\n          -  Inflammatory arthritis, septic arthritis, gout, pseudogout, Paget's disease,\n             ochronosis, acromegaly, hemochromatosis, tumors, collagen mutations.\n\n          -  Total meniscectomy\n\n          -  Malalignment\n\n          -  Evidence of osteoarthritis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01947374", 
            "org_study_id": "017-05-INR"
        }, 
        "intervention": [
            {
                "arm_group_label": "Chondrocyte implantation", 
                "description": "Each implant contains 6,000,000 autologous chondrocytes.", 
                "intervention_name": "Matrix encapsulated chondrocyte implantation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Microfractures", 
                "description": "Is an awl that allow perforation of the subchondral bone.", 
                "intervention_name": "Microfracture awl", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cartilage", 
            "Articular"
        ], 
        "lastchanged_date": "September 17, 2013", 
        "link": {
            "description": "Official site of the INR", 
            "url": "http://www.inr.gob.mx"
        }, 
        "location": {
            "contact": {
                "email": "aldoizag@gmail.com", 
                "last_name": "Aldo F Izaguirre, M.D.", 
                "phone": "525559991000", 
                "phone_ext": "1960"
            }, 
            "facility": {
                "address": {
                    "city": "Mexico City", 
                    "country": "Mexico", 
                    "zip": "14389"
                }, 
                "name": "National Institute of Rehabilitation"
            }, 
            "investigator": [
                {
                    "last_name": "Clemente Ibarra, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Enrique Villalobos, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Aldo Izaguirre, M.D. M.Sc.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "Matrix-encapsulated Arthroscopic Autologous Chondrocyte Implantation Versus Microfractures for Articular Cartilage Regeneration. Randomised Clinical Trial.", 
        "overall_contact": {
            "email": "aldoizag@gmail.com", 
            "last_name": "Aldo F Izaguirre, M.D.", 
            "phone": "525559991000", 
            "phone_ext": "19607"
        }, 
        "overall_contact_backup": {
            "email": "villalobosenrique@hotmail.com", 
            "last_name": "Enrique Villalobos, M.D.", 
            "phone": "525559991000", 
            "phone_ext": "19607"
        }, 
        "overall_official": [
            {
                "affiliation": "INR", 
                "last_name": "Clemente Ibarra, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "INR", 
                "last_name": "Luis G Ibarra, M.D.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "INR", 
                "last_name": "Enrique Villalobos, M.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "INR", 
                "last_name": "Aldo F Izaguirre, M.D. M.Sc.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Mexico: Federal Commission for Sanitary Risks Protection", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Special magnetic resonance imaging technique for measurement of collagen and water content, expressed in milliseconds.", 
            "measure": "MRI T2 Mapping", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "reference": [
            {
                "PMID": "17681210", 
                "citation": "Masri M, Lombardero G, Velasquillo C, Mart\u00ednez V, Neri R, Villegas H, Ibarra C. Matrix-encapsulation cell-seeding technique to prevent cell detachment during arthroscopic implantation of matrix-induced autologous chondrocytes. Arthroscopy. 2007 Aug;23(8):877-83."
            }, 
            {
                "PMID": "19462773", 
                "citation": "Ibarra-Ponce de Le\u00f3n JC, Velasquillo-Mart\u00ednez MC, Izaguirre A, Villalobos-C\u00f3rdova E, Masri M, Ibarra-Ibarra LG. [Cartilage repair: cell-based techniques]. Acta Ortop Mex. 2009 Jan-Feb;23(1):38-44. Review. Spanish."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01947374"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Instituto Nacional de Rehabilitacion", 
            "investigator_full_name": "Aldo Izaguirre", 
            "investigator_title": "Dr./Study Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Clinical assessment with validated knee scores, and adverse effects register are taken.", 
            "measure": "Clinical evaluation", 
            "safety_issue": "Yes", 
            "time_frame": "0, 10, 30 days; 3, 6, 9 ,12, 24, 36 months"
        }, 
        "source": "Instituto Nacional de Rehabilitacion", 
        "sponsors": {
            "collaborator": {
                "agency": "National Council of Science and Technology, Mexico", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Instituto Nacional de Rehabilitacion", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}